Results 211 to 220 of about 101,002 (279)

Author reply: Comment to “Atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property” [PDF]

, 2012
Sho‐ichi Yamagishi
openalex   +1 more source

Comparative Analysis of the Total Proteome in Nonalcoholic Steatohepatitis: Identification of Potential Biomarkers. [PDF]

Mol Cell Proteomics
Ates E, My Ong HT, Yu SM, Kim JH, Kang MJ.   +4 more
europepmc   +1 more source

MiR-130a-3p attenuates activation and induces apoptosis of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis by directly targeting TGFBR1 and TGFBR2 [PDF]

, 2017
Yang Wang, Jinghua Du, Xuemin Niu, Na Fu, Rongqi Wang, Yuguo Zhang, Suxian Zhao, Dianxing Sun, Yuemin Nan   +8 more
openalex   +1 more source

Artificial Intelligence in Identifying Patients With Undiagnosed Nonalcoholic Steatohepatitis. [PDF]

J Health Econ Outcomes Res
Baser O, Samayoa G, Yapar N, Baser E.
europepmc   +1 more source

Table S1 from Inhibition of the Cell Death Pathway in Nonalcoholic Steatohepatitis (NASH)-Related Hepatocarcinogenesis Is Associated with Histone H4 lysine 16 Deacetylation

, 2023
Aline de Conti, Kostiantyn Dreval, Volodymyr Tryndyak, Orish Ebere Orisakwe, Sharon A. Ross, Frederick A. Beland, Igor P. Pogribny   +6 more
openalex   +1 more source

Insulinoma in Patient With Nonalcoholic Steatohepatitis. [PDF]

Cureus, 2023
Cain D, Anguiano-Albarran R, Obi F, Pradeep S, Mudrovich S, Simien M.   +5 more
europepmc   +1 more source

Inhibition of 11β‐Hydroxysteroid dehydrogenase‐1 with AZD4017 in patients with nonalcoholic steatohepatitis or nonalcoholic fatty liver disease: A randomized, double‐blind, placebo‐controlled, phase II study

, 2022
Yogesh Yadav, Kelly T. Dunagan, Rachita Khot, Sudhakar K. Venkatesh, John D. Port, Alfonso Galderisi, Claudio Cobelli, Craig D. Wegner, Ananda Basu, Rickey E. Carter, Rita Basu   +10 more
openalex   +1 more source

High uric acid exacerbates nonalcoholic steatohepatitis through NLRP3 inflammasome and gasdermin D-mediated pyroptosis. [PDF]

J Biol Chem
Xu Z, Tang C, Song X, Liu Z, Zhou J, Shi Q, Yu C, Xu C.   +7 more
europepmc   +1 more source

Betel Chewing and Nonalcoholic Steatohepatitis [PDF]

, 2018
Wissam Bleibel, Saad Saleem
openalex   +1 more source

Role of the FOXM1/CMA/ER stress axis in regulating the progression of nonalcoholic steatohepatitis. [PDF]

Clin Transl Med
Ma S, Xia E, Zhang M, Hu Y, Tian S, Zheng X, Li B, Ma G, Su R, Sun K, Fan Q, Yang F, Guo G, Guo C, Shang Y, Zhou X, Zhou X, Wang J, Han Y.   +18 more
europepmc   +1 more source